NAD50012312025-13 — Nexaph NAD+
Independently TestedNexaph | NAD+, last activity 5 days ago
2 related batch concerns
Get notified when a lab result is posted, a group test forms, or this batch is flagged by the community.
Test Results
The label says 500 mg. Janoshik weighed 579.8 mg — 16% more than the label. Your dose depends on what is really in the vial, so the steps below use the measured amount.
Draw
17 units
on a U-100 insulin syringe, for 50 mg
Going by the label you would draw 20 units — which from this vial is actually 58 mg, not 50 mg.
- The vial holds dry powder: 579.8 mg of NAD+, as weighed.
- Water spreads that powder evenly through the liquid: 579.8 mg ÷ 2 ml = 289.9 mg per ml.
- An insulin syringe counts in units, 100 to the ml, so each unit carries 2.9 mg.
- Your dose divided by that: 50 mg ÷ 2.9 mg = 17 units.
The water changes how many units a dose takes, never how much peptide you get. Twice the water means twice the units for the same dose. What sets the dose is how much is in the vial — which is why the measured amount matters.
Arithmetic, not medical advice. Assumes a U-100 syringe and that the powder fully dissolves. The figure is from the vial that was tested; yours is from the same lot but was not weighed itself.
Related batches
5 of 5 tested
Community Intelligence
- 1 concern report involving JP20260011
- 1 concern report involving SJ26-4-01
Reported against other Nexaph NAD+ batches, not this one.
Also known as: NAD5001231202513
Activity
No community activity tracked yet.
Vendor
Nexaph